Skip to main content
NCBI home page
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1955 Jun;27(6):451–486.

The Clinical Evaluation and Management of Hypertension §

Allan V N Goodyer, Ernest Rosenthal, Carl A Jaeger
PMCID: PMC2599693  PMID: 14397436

Full text

PDF
451

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASHTON N. Vascular changes in diabetes with particular reference to the retinal vessels; preliminary report. Br J Ophthalmol. 1949 Jul;33(7):407–420. doi: 10.1136/bjo.33.7.407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. ASSALI N. S. Studies on Veratrum viride: standardization of intravenous technique and its clinical application in the treatment of toxemia of pregnancy. Am J Obstet Gynecol. 1950 Aug;60(2):387–394. doi: 10.1016/0002-9378(50)90480-7. [DOI] [PubMed] [Google Scholar]
  3. BRADLEY S. E., BRADLEY G. P., TYSON C. J., CURRY J. J., BLAKE W. D. Renal function in renal diseases. Am J Med. 1950 Dec;9(6):766–798. doi: 10.1016/0002-9343(50)90292-0. [DOI] [PubMed] [Google Scholar]
  4. BRADLEY S. E. Physiology of essential hypertension. Am J Med. 1948 Mar;4(3):398–415. doi: 10.1016/0002-9343(48)90257-5. [DOI] [PubMed] [Google Scholar]
  5. BRUST A. A., REISER M. F., FERRIS E. G., Jr Evaluation of neurogenic control of blood pressure in hypertension with tetraethylammonium chloride and spinal anesthesia. J Clin Invest. 1951 Sep;30(9):925–931. doi: 10.1172/JCI102513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. BYROM F. B. The pathogenesis of hypertensive encephalopathy and its relation to the malignant phase of hypertension; experimental evidence from the hypertensive rat. Lancet. 1954 Jul 31;267(6831):201–211. doi: 10.1016/s0140-6736(54)91821-8. [DOI] [PubMed] [Google Scholar]
  7. Ballantyne A. J., Loewenstein A. RETINAL MICRO-ANEURYSMS AND PUNCTATE HAEMORRHAGES. Br J Ophthalmol. 1944 Dec;28(12):593–598. doi: 10.1136/bjo.28.12.593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Burch G. E., Cohn A. E., Neumann C. REACTIVITY OF INTACT BLOOD VESSELS OF THE FINGERS AND TOES TO SENSORY STIMULI IN NORMAL RESTING ADULTS, IN PATIENTS WITH HYPERTENSION, AND IN SENILE SUBJECTS. J Clin Invest. 1942 Nov;21(6):655–664. doi: 10.1172/JCI101342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. CAHILL G. F. Pheochromocytoma. Bull N Y Acad Med. 1953 Oct;29(10):749–764. [PMC free article] [PubMed] [Google Scholar]
  10. CORCORAN A. C., PAGE I. H., MASSON G. M. C., TAYLOR R. D., DUSTAN H. Hypertension and hypertensive cardiovascular disease; review of recent observations. AMA Arch Intern Med. 1951 May;87(5):732–770. doi: 10.1001/archinte.1951.03810050110011. [DOI] [PubMed] [Google Scholar]
  11. DAVIES D. F., OLSEN N. S., SCHROEDER H. A. Pressor substances in arterial hypertension. IV. Quantitative and qualitative studies of pherentasin. Circulation. 1952 Mar;5(3):380–389. doi: 10.1161/01.cir.5.3.380. [DOI] [PubMed] [Google Scholar]
  12. DOYLE A. E., SMIRK F. H. The use of the pure veratrum alkaloids neogermitrine and protoveratrine in hypertension. Br Heart J. 1953 Oct;15(4):439–449. doi: 10.1136/hrt.15.4.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. DWYER H. L., Jr Normal blood pressure range. Conn State Med J. 1951 Aug;15(8):693–697. [PubMed] [Google Scholar]
  14. EHRLICH A., BRODOFF B. N., RUBIN I. L., BERKMAN J. I. Malignant hypertension in a patient with renal artery occlusions. AMA Arch Intern Med. 1953 Oct;92(4):591–601. doi: 10.1001/archinte.1953.00240220139017. [DOI] [PubMed] [Google Scholar]
  15. EVANS J. A., RUBITSKY H. J., BARTELS C. C., BARTELS E. C. Re-evaluation of the reliability of pharmacologic and cold pressor studies in hypertension and pheochromocytoma. Am J Med. 1951 Oct;11(4):448–467. doi: 10.1016/0002-9343(51)90180-5. [DOI] [PubMed] [Google Scholar]
  16. FERTIG H. H., TAYLOR R. D., CORCORAN A. C., PAGE I. H. The renal manifestations of pheochromocytoma: report of a case. Ann Intern Med. 1951 Dec;35(6):1358–1364. doi: 10.7326/0003-4819-35-6-1358. [DOI] [PubMed] [Google Scholar]
  17. FINNERTY F. A., Jr Does vascular damage follow toxemia of pregnancy? J Am Med Assoc. 1954 Mar 27;154(13):1075–1079. doi: 10.1001/jama.1954.02940470027006. [DOI] [PubMed] [Google Scholar]
  18. FINNERTY F. A., Jr Hypertensive toxemias of pregnancy; a simplified method of management using a purified extract of Veratrum viride. N Engl J Med. 1952 Apr 24;246(17):646–651. doi: 10.1056/NEJM195204242461703. [DOI] [PubMed] [Google Scholar]
  19. FRANT R., GROEN J. Prognosis of vascular hypertension; a 9 year follow-up study of 418 cases. Arch Intern Med (Chic) 1950 May;85(5):727–750. doi: 10.1001/archinte.1950.00230110002001. [DOI] [PubMed] [Google Scholar]
  20. GIFFORD R. W., Jr, ROTH G. M., KVALE W. F. Evaluation of new adrenolytic drug (regitine) as test for pheochromocytoma. J Am Med Assoc. 1952 Aug 30;149(18):1628–1634. doi: 10.1001/jama.1952.02930350016005. [DOI] [PubMed] [Google Scholar]
  21. GOLDENBERG M., ARANOW H., Jr, SMITH A. A., FABER M. Pheochromocytoma and essential hypertensive vascular disease. AMA Arch Intern Med. 1950 Dec;86(6):823–836. doi: 10.1001/archinte.1950.00230180028003. [DOI] [PubMed] [Google Scholar]
  22. GOLDENBERG M. Adrenal medullary function. Am J Med. 1951 May;10(5):627–641. doi: 10.1016/0002-9343(51)90332-4. [DOI] [PubMed] [Google Scholar]
  23. GOLDENBERG M., SERLIN I., EDWARDS T., RAPPORT M. M. Chemical screening methods for the diagnosis of pheochromocytoma. I. Nor-epinephrine and epinephrine in human urine. Am J Med. 1954 Mar;16(3):310–327. doi: 10.1016/0002-9343(54)90349-6. [DOI] [PubMed] [Google Scholar]
  24. GRAHAM G. K., TAYLOR J. A., ELLIS L. B., GREENBERG D. J., ROBBINS S. L. Studies in mitral stenosis. II. A correlation of postmortem findings with the clinical course of the disease in 101 cases. AMA Arch Intern Med. 1951 Oct;88(4):532–547. doi: 10.1001/archinte.1951.03810100116012. [DOI] [PubMed] [Google Scholar]
  25. GRIEP A. H., BARRY G. R., HALL W. C., HOOBLER S. W. The prognosis in arterial hypertension; report on 117 patients under 53 years of age followed 8 to 10 years. Am J Med Sci. 1951 Mar;221(3):239–249. [PubMed] [Google Scholar]
  26. Grimson K. S., Orgain E. S., Anderson B., Broome R. A., Longino F. H. Results of Treatment of Patients with Hypertension by Total Thoracic and Partial to Total Lumbar Sympathectomy, Splanchnicectomy and Celiac Ganglionectomy. Ann Surg. 1949 Jun;129(6):850–871. [PMC free article] [PubMed] [Google Scholar]
  27. HAMMARSTROM S., BECHGAARD P. Prognosis in arterial hypertension; comparison between 251 patients after sympathectomy and selected series of 435 non-operated patients. Am J Med. 1950 Jan;8(1):53–56. doi: 10.1016/0002-9343(50)90342-1. [DOI] [PubMed] [Google Scholar]
  28. HANDLER P., BERNHEIM F. Effect of choline deficiency on ACTH production and on hypertension of subtotally nephrectomized rats. Am J Physiol. 1950 Aug 1;162(2):375–378. doi: 10.1152/ajplegacy.1950.162.2.375. [DOI] [PubMed] [Google Scholar]
  29. HATCH F. T., WERTHEIM A. R., EURMAN G. H., WATKIN D. M., FROEB H. F., EPSTEIN H. A. Effects of diet in essential hypertension. III. Alterations in sodium chloride, protein and fat intake. Am J Med. 1954 Oct;17(4):499–513. doi: 10.1016/0002-9343(54)90125-4. [DOI] [PubMed] [Google Scholar]
  30. HENSLER L. Hypertonietherapie mit Serpasil, einem Alkaloid der Rauwolfia serpentina. Schweiz Med Wochenschr. 1953 Nov 28;83(48):1162–1166. [PubMed] [Google Scholar]
  31. HEYMANS C., VAN DEN HEUVEL-HEYMANS G. New aspects of blood pressure regulation. Circulation. 1951 Oct;4(4):581–586. doi: 10.1161/01.cir.4.4.581. [DOI] [PubMed] [Google Scholar]
  32. HOWARD J. E., BERTHRONG M., SLOAN R. D., YENDT E. R. Relief of malignant hypertension by nephrectomy in four patients with unilateral renal vascular disease. Trans Assoc Am Physicians. 1953;66:164–169. [PubMed] [Google Scholar]
  33. JEFFERS W. A., ZINTEL H. A., HAFKENSCHIEL J. H., HILLS A. G., SELLERS A. M., WOLFERTH C. C. Evaluation of adrenal resection and sympathectomy in ninety-nine persons with hypertension. J Am Med Assoc. 1953 Dec 26;153(17):1502–1505. doi: 10.1001/jama.1953.02940340004002. [DOI] [PubMed] [Google Scholar]
  34. JEFFERS W. A., ZINTEL H. A., HILLS A. G., HAFKENSCHIEL J. H., LANGFELD S. B., SELLERS A. M., WOLFERTH C. C. Further observations on patients with severe hypertension subjected to adrenal resection and sympathectomy. Ann Intern Med. 1954 Aug;41(2):221–231. doi: 10.7326/0003-4819-41-2-221. [DOI] [PubMed] [Google Scholar]
  35. JOHNSON R. L., FREIS E. D., SCHNAPER H. W. Clinical evaluation of 1-hydrazinophthalazine (C-5968) in hypertension, with special reference to alternating treatment with hexamethonium. Circulation. 1952 Jun;5(6):833–841. doi: 10.1161/01.cir.5.6.833. [DOI] [PubMed] [Google Scholar]
  36. KEMPNER W. Treatment of hypertensive vascular disease with rice diet. Am J Med. 1948 Apr;4(4):545–577. doi: 10.1016/0002-9343(48)90441-0. [DOI] [PubMed] [Google Scholar]
  37. LIVESAY W. R., MOYER J. H., MILLER S. I. Treatment of hypertension with Rauwolfia serpentina alone and combined with other drugs: results in eighty-four cases. J Am Med Assoc. 1954 Jul 17;155(12):1027–1035. doi: 10.1001/jama.1954.03690300005002. [DOI] [PubMed] [Google Scholar]
  38. LOFFLER W., ESSELLIER A. F., PROTT F., WEGMANN A. Hochdruckbehandlung mit einem Rauwolfiaalkaloid, Serpasil; klinische Beobachtungen. Schweiz Med Wochenschr. 1953 Oct 17;83(42):1012–1015. [PubMed] [Google Scholar]
  39. MASTER A. M., DUBLIN L. I., MARKS H. H. The normal blood pressure range and its clinical implications. J Am Med Assoc. 1950 Aug 26;143(17):1464–1470. doi: 10.1001/jama.1950.02910520006004. [DOI] [PubMed] [Google Scholar]
  40. MERRILL J. P. The rôle of the adrenal in hypertension. Ann Intern Med. 1952 Nov;37(5):966–971. doi: 10.7326/0003-4819-37-5-966. [DOI] [PubMed] [Google Scholar]
  41. MORROW J. D., SCHROEDER H. A., PERRY H. M., Jr Studies on the control of hypertension by hyphex. II. Toxic reactions and side effects. Circulation. 1953 Dec;8(6):829–839. doi: 10.1161/01.cir.8.6.829. [DOI] [PubMed] [Google Scholar]
  42. MOYER J. H., HANDLEY C. A., HUGGINS R. A. Some pharmacodynamic effects of 1-hydrazinophthalazine (C-5968) with particular reference to renal function and cardiovascular response. J Pharmacol Exp Ther. 1951 Dec;103(4):368–376. [PubMed] [Google Scholar]
  43. MOYER J. H. Hydrallazine (apresoline) hydrochloride; pharmacological observations and clinical results in the therapy of hypertension. AMA Arch Intern Med. 1953 Apr;91(4):419–439. doi: 10.1001/archinte.1953.00240160005002. [DOI] [PubMed] [Google Scholar]
  44. MOYER J. H., MILLER S. I., FORD R. V. Orally administered hexamethonium chloride in hypertension. J Am Med Assoc. 1953 Jul 18;152(12):1121–1129. doi: 10.1001/jama.1953.03690120037010. [DOI] [PubMed] [Google Scholar]
  45. MOYER J. H., MILLER S. I., TASHNER A. B., SNYDER H., BOWMAN R. O. Malignant hypertension and hypertensive encephalopathy. Am J Med. 1953 Feb;14(2):175–183. doi: 10.1016/0002-9343(53)90017-5. [DOI] [PubMed] [Google Scholar]
  46. PAGE I. H. Treatment of essential and malignant hypertension. J Am Med Assoc. 1951 Dec 1;147(14):1311–1318. doi: 10.1001/jama.1951.03670310001001. [DOI] [PubMed] [Google Scholar]
  47. PALMER R. S., LOOFBOUROW D., DOERING C. R. Prognosis in essential hypertension; 8-year follow-up study of 430 patients on conventional medical treatment. N Engl J Med. 1948 Dec 23;239(26):990–994. doi: 10.1056/NEJM194812232392602. [DOI] [PubMed] [Google Scholar]
  48. PERERA G. A. Cortisone and blood pressure. Proc Soc Exp Biol Med. 1951 Mar;76(3):583–585. doi: 10.3181/00379727-76-18566. [DOI] [PubMed] [Google Scholar]
  49. PERERA G. A. Diagnosis and natural history of hypertensive vascular disease. Am J Med. 1948 Mar;4(3):416–422. doi: 10.1016/0002-9343(48)90258-7. [DOI] [PubMed] [Google Scholar]
  50. PERERA G. A., HAELIG A. W. Clinical characteristics of hypertension associated with unilateral renal disease. Circulation. 1952 Oct;6(4):549–552. doi: 10.1161/01.cir.6.4.549. [DOI] [PubMed] [Google Scholar]
  51. PERRY H. M., Jr, SCHROEDER H. A. Syndrome simulating collagen disease caused by hydralazine (Apresoline). J Am Med Assoc. 1954 Feb 20;154(8):670–673. doi: 10.1001/jama.1954.02940420032009. [DOI] [PubMed] [Google Scholar]
  52. RALL J. E., ODEL H. M. Congenital polycystic disease of the kidney; review of the literature and data on 207 cases. Am J Med Sci. 1949 Oct;218(4):399–407. doi: 10.1097/00000441-194910000-00007. [DOI] [PubMed] [Google Scholar]
  53. REINHARDT D. J., WALDRON J. M. Lupus erythematosus-like syndrome complicating hydralazine (apresoline) therapy. J Am Med Assoc. 1954 Aug 21;155(17):1491–1492. doi: 10.1001/jama.1954.73690350001010. [DOI] [PubMed] [Google Scholar]
  54. RIVEN S. S., POCOCK D. G., KORY R. C., ROEHM D. C., ANDERSON R. S., MENEELY G. R. The control of hypertension with 1-hydrazinophthalazine (apresoline). Am J Med. 1953 Feb;14(2):160–167. doi: 10.1016/0002-9343(53)90015-1. [DOI] [PubMed] [Google Scholar]
  55. ROBERTS L. N., SMILEY J. R., MANNING G. W. A comparison of direct and indirect blood-pressure determinations. Circulation. 1953 Aug;8(2):232–242. doi: 10.1161/01.cir.8.2.232. [DOI] [PubMed] [Google Scholar]
  56. SCHAFFER A. J., MARKOWITZ M. Hypertension treated by nephrectomy; a report of 4 additional cases and a re-evaluation of prognosis and criteria for operation. Am J Med Sci. 1954 Apr;227(4):417–425. doi: 10.1097/00000441-195404000-00008. [DOI] [PubMed] [Google Scholar]
  57. SCHOTTSTAEDT M. F., SOKOLOW M. The natural history and course of hypertension with papilledema (malignant hypertension). Am Heart J. 1953 Mar;45(3):331–362. doi: 10.1016/0002-8703(53)90147-1. [DOI] [PubMed] [Google Scholar]
  58. SCHROEDER H. A., FUTCHER P. H., GOLDMAN M. L. The effects of the rice diet upon the blood pressure of hypertensive individuals. Ann Intern Med. 1949 Apr;30(4):713–732. doi: 10.7326/0003-4819-30-4-713. [DOI] [PubMed] [Google Scholar]
  59. SCHROEDER H. A., MORROW J. D., PERRY H. M., Jr Studies on the control of hypertension by hyphex. I. Effects on blood pressure. Circulation. 1953 Nov;8(5):672–680. doi: 10.1161/01.cir.8.5.672. [DOI] [PubMed] [Google Scholar]
  60. SCHROEDER H. A., MORROW J. D., PERRY H. M., Jr Studies on the control of hypertension by hyphex. V. Effects on the course of the malignant stage. Circulation. 1954 Sep;10(3):321–330. doi: 10.1161/01.cir.10.3.321. [DOI] [PubMed] [Google Scholar]
  61. SCHROEDER H. A. Pathogenesis of hypertension. Am J Med. 1951 Feb;10(2):189–209. doi: 10.1016/0002-9343(51)90241-0. [DOI] [PubMed] [Google Scholar]
  62. SHACKMAN N. H., SWILLER A. I., MORRISON M. Syndrome simulating acute disseminated lupus erythematosus: appearance after hydralazine (apresoline) therapy. J Am Med Assoc. 1954 Aug 21;155(17):1492–1494. doi: 10.1001/jama.1954.73690350002010a. [DOI] [PubMed] [Google Scholar]
  63. SMIRK F. H. Action of a new methonium compound in arterial hypertension; pentamethylene 1 : 5-bis-n-(n-methyl-pyrrolidinium) bitartrate (M. & B. 2050A). Lancet. 1953 Mar 7;1(6758):457–464. doi: 10.1016/s0140-6736(53)91640-7. [DOI] [PubMed] [Google Scholar]
  64. SMIRK F. H. Practical details of the methonium treatment of high blood pressure. N Z Med J. 1950 Dec;49(274):637–643. [PubMed] [Google Scholar]
  65. SMIRK F. H. Practical details of the treatment of hypertension by hexamethonium salts and by pentamethylene 1:5-bis-N-(N-methylpyrrolidinium) bitartrate (M. & B. 2050A). N Z Med J. 1953 Oct;52(291):325–348. [PubMed] [Google Scholar]
  66. SMITH H. W. Hypertension and urologic disease. Am J Med. 1948 May;4(5):724–743. doi: 10.1016/s0002-9343(48)90396-9. [DOI] [PubMed] [Google Scholar]
  67. SMITHWICK R. H. An evaluation of the surgical treatment of hypertension. Bull N Y Acad Med. 1949 Nov;25(11):698–716. [PMC free article] [PubMed] [Google Scholar]
  68. STUNKARD A. J., EURMAN G. H., WACHSPRESS M., WERTHEIM A. R. Treatment of hypertensive disease with hydralazine; comparison of its action with that of low sodium diet in hospitalized patients. Am J Med. 1954 Nov;17(5):712–721. doi: 10.1016/0002-9343(54)90030-3. [DOI] [PubMed] [Google Scholar]
  69. TAYLOR R. D., CORCORAN A. C., PAGE I. H. Increased cerebrospinal fluid pressure and papilledema in malignant hypertension. AMA Arch Intern Med. 1954 Jun;93(6):818–824. doi: 10.1001/archinte.1954.00240300012002. [DOI] [PubMed] [Google Scholar]
  70. TAYLOR R. D., DUSTAN H. P., CORCORAN A. C., PAGE I. H. Evaluation of l-hydrazinophthalazine (apresoline) in treatment of hypertensive disease. AMA Arch Intern Med. 1952 Dec;90(6):734–749. doi: 10.1001/archinte.1952.00240120009002. [DOI] [PubMed] [Google Scholar]
  71. TAYLOR R. D., PAGE I. H. Further studies of the cerebral chemoreceptor buffers as influenced by vasoconstrictor and vasodilator drugs and veratrum viride. Circulation. 1951 Aug;4(2):184–189. doi: 10.1161/01.cir.4.2.184. [DOI] [PubMed] [Google Scholar]
  72. THORN G. W., FORSHAM P. H., FRAWLEY T. F., HILL S. R., Jr, ROCHE M., STAEHELIN D., WILSON D. L. The clinical usefulness of ACTH and cortisone. N Engl J Med. 1950 May 18;242(20):783–793. doi: 10.1056/NEJM195005182422005. [DOI] [PubMed] [Google Scholar]
  73. VAN BERGEN F. H., WEATHERHEAD D. S., TRELOAR A. E., DOBKIN A. B., BUCKLEY J. J. Comparison of indirect and direct methods of measuring arterial blood pressure. Circulation. 1954 Oct;10(4):481–490. doi: 10.1161/01.cir.10.4.481. [DOI] [PubMed] [Google Scholar]
  74. VERNAGLIA J. B. Double uterus with horn menstruating into the abdomen. N Engl J Med. 1948 Nov 11;239(20):732–736. doi: 10.1056/NEJM194811112392002. [DOI] [PubMed] [Google Scholar]
  75. WALLIS T. E., ROHATGI S. The pharmacognosy of Rauwolfia. J Pharm Pharmacol. 1949 May;1(5):292–305. doi: 10.1111/j.2042-7158.1949.tb12417.x. [DOI] [PubMed] [Google Scholar]
  76. WATERS L. L. Changes in the coronary arteries of the dog following injections of allylamine. Am Heart J. 1948 Feb;35(2):212–220. doi: 10.1016/0002-8703(48)90101-x. [DOI] [PubMed] [Google Scholar]
  77. WATERS L. L., DeSUTO-NAGY G. I. Circulatory factors in the pathogenesis of experimental arteriolar necrosis. Yale J Biol Med. 1950 Jul;22(6):751–766. [PMC free article] [PubMed] [Google Scholar]
  78. WATKIN D. M., FROEB H. F., HATCH F. T., GUTMAN A. B. Effects of diet in essential hypertension. I. Baseline study: effects in 86 cases of prolonged hospitalization on regular hospital diet. Am J Med. 1950 Oct;9(4):428–440. doi: 10.1016/0002-9343(50)90199-9. [DOI] [PubMed] [Google Scholar]
  79. WHITELAW G. P., SMITHWICK R. H. Effect of extensive sympathectomy upon blood pressure responses and levels. Angiology. 1951 Jun;2(3):157–172. doi: 10.1177/000331975100200302. [DOI] [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES